U.S. Markets closed

Biogen Inc. (BIIB)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
280.32-0.25 (-0.09%)
At close: 4:00PM EDT
People also watch
CELGREGNGILDAMGNALXN
Full screen
Previous Close280.57
Open282.33
Bid278.80 x 2600
Ask280.83 x 600
Day's Range277.58 - 284.46
52 Week Range223.02 - 333.65
Volume2,439,595
Avg. Volume1,614,080
Market Cap59.88B
Beta0.45
PE Ratio (TTM)17.56
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga2 days ago

    Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold

    Biotech stocks have been on a tear in the past week, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB ) up 8.8 percent. However, despite the run-up, Deutsche Bank sees more upside ahead for ...

  • Capital Cube3 days ago

    Biogen, Inc. – Value Analysis (NASDAQ:BIIB) : June 22, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Biogen, Inc. a score of 84. Our analysis is based on comparing Biogen, Inc. with the following peers – Amgen Inc., Celgene Corporation, Gilead Sciences, Inc., Johnson & Johnson, AbbVie, Inc., Pfizer Inc., Sanofi Sponsored ADR, Acorda Therapeutics, Inc., Sangamo Therapeutics, Inc. and Bio-Rad Laboratories, Inc. Class ... Read more (Read more...)

  • Futures: These 2 Big Breakouts Highlight New Market Leadership
    Investor's Business Daily4 days ago

    Futures: These 2 Big Breakouts Highlight New Market Leadership

    Nasdaq 100 futures edged higher Thursday morning as Oracle surged on strong earnings. On Wednesday, Celgene broke out as biotechs and business software increasingly lead the market rally.